期刊文献+

肿瘤靶向DNA载体转铁蛋白-多聚乙烯亚胺体外转染 被引量:5

Transferrin-polythylenimine as a tumor-targeted vector for murine interleukin-12 gene transfer to the mouse osteosarcoma cells
原文传递
导出
摘要 目的评价转铁蛋白-多聚乙烯亚胺(Tf-PEI)靶向性转染小鼠骨肉瘤细胞的可行性。以Tf-PEI为载体,将小鼠白细胞介素(IL)-12基因导入小鼠骨肉瘤细胞。方法以Tf-PEI为载体,将绿色荧光蛋白基因和小鼠IL-12基因分别导入小鼠骨肉瘤细胞,并检测其转染效率。以游离转铁蛋白竞争性拮抗Tf-PEI,并观察它对转染效率的影响。结果Tf-PEI可以高效的、靶向性的转染小鼠骨肉瘤细胞。当N/P比值为5时,Tf-PEI的转染效率最高。游离转铁蛋白能够显著的拮抗Tf-PEI的转染。Tf-PEI还可以成功的将小鼠IL-12基因导入小鼠骨肉瘤细胞。结论Tf-PEI是一种高效率、低毒性、肿瘤靶向性的基因转染载体,可以广泛应用于恶性肿瘤靶向性基因治疗的试验。 Objective To investigate the feasibility and efficiency of transferrin-polyethylenimine (Tf-PEI) for tumor-targeted gene transfer to murine osteosarcoma. Using Tf-PEI as the vector, to transfer murine interleukin-t2 (mIL-t2) gene into mouse osteosarcoma cells. Methods Using Tf-PEI as the vector, murine osteosarcoma cells were transfected with plasmid DNA coding for murine IL-12 and green fluorescent protein (GFP),and the expression of the transduced gene was detected. By using free transferrin to inhibit Tf-PEI, the influence on the transfection of Tf-PEI was observed. Results Tf-PEI could effectively and specifically deliver murine IL-12 gene and luciferase gene into murine osteosarcoma cells. When N/P ratio was 5 ,the transfection efficiency of Tf-PEI was highest. The transfection can be specifi- cally inhibited by free transferrin. Conclusion Tf-PEI is a high efficiency and low cytotoxicity tumortargeted vector. It can be widely used in the area of tumor-targeted gene therapy.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2006年第12期1519-1521,共3页 Chinese Journal of Experimental Surgery
关键词 多聚乙烯亚胺 转铁蛋白 骨肉瘤 白细胞介素12 Polyethylenimine Transferrin Osteosarcoma Interleukin- 12
  • 相关文献

参考文献9

  • 1Jia SF, Worth LL, Densmore CL, et al. Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector. Cancer Gene Ther, 2002,9 : 260-266.
  • 2Pollard H, Remy JS, Loussouarn G, et al. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem, 1998,273 : 7507-7511.
  • 3Godbey WT, Barry MA, Saggau P, et al. Poly (ethylenimine) -mediated transfection:a new paradigm for gene delivery. J Biomed Mater Res,2000,51 : 321-328.
  • 4Kircheis R, Kichler A, WaUner G, et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther, 1997, 4:409-418.
  • 5Gharwan H,Wightman L, Kircheis R,et al. Nonviral gene transfer into fetal mouse livers (a comparison between the cationic polymer PEI and naked DNA). Gene Ther,2003,10:810-817.
  • 6Kircheis R, Wightman L, Kursa M, et al. Tumor-targeted gene delivery:an attractive strategy to use highly active effector molecules in cancer treatment, Gene Ther, 2002,9:731-735.
  • 7Kunath K, Merdan T, Hegener O, et al. Integrin targeting using RGDPEI conjugates for in vitro gene transfer. J Gene Med, 2003,5:588-599.
  • 8Ogris M, Walker G, Blessing T, et al. Tumor-targeted gene therapy:strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes.J Control Release,2003,91 : 173-181.
  • 9Kircheis R, Wightman L, Schreiber A, et al. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther, 2001,8 : 28-40.

同被引文献54

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部